PWA
REGN icon

Physician Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Physician Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.9K Sell
64
-4
-6% -$2.72K ﹤0.01% 486
2026
Q1 		$52.5K Buy
68
+4
+6% +$3.06K 0.01% 389
2025
Q4 		$49.4K Buy
64
+7
+12% +$4.75K 0.01% 394
2025
Q3 		$32K Buy
57
+14
+33% +$7.92K ﹤0.01% 464
2025
Q2 		$22.6K Buy
43
+10
+30% +$5.58K ﹤0.01% 491
2025
Q1 		$20.9K Sell
33
-19
-37% -$13.1K ﹤0.01% 475
2024
Q4 		$37K Buy
+52
New +$43.6K 0.01% 390

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Physician Wealth Advisors's REGN Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 5.9% in Q2 2026, selling an estimated $2.72K and leaving 64 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Physician Wealth Advisors first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $52.5K in Q1 2026. 248 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Physician Wealth Advisors held 64 shares of Regeneron Pharmaceuticals worth $39.9K as of Q2 2026.
  • Physician Wealth Advisors sold 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #486 holding.
  • Physician Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Regeneron Pharmaceuticals position peaked at $52.5K in Q1 2026.
  • 248 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.